Neurimmune is a biotech company translating human immune memory into next generation antibody therapeutics. Neurimmune’s pipeline includes human antibody programs for degenerative diseases of the central nervous system such as AD, PD and ALS, as well as for cardiomyopathy and type-2 diabetes.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business